ADMA BIOLOGICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Adma Biologics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Adma Biologics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 235M shares, a 4.13% increase year-over-year.
  • Adma Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 224M shares, a 13.2% increase from 2022.
  • Adma Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 198M shares, a 41.8% increase from 2021.
  • Adma Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 140M shares, a 62% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 235M +9.29M +4.13% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 232M +9.73M +4.37% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 229M +6.95M +3.13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 224M +26.1M +13.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 225M +28.9M +14.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 223M +26.3M +13.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 222M +26M +13.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 198M +58.3M +41.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 196M +62.6M +46.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 196M +68.9M +54.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 196M +80.2M +69.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 140M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 134M +46.1M +52.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 127M +41.1M +47.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 116M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 87.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 86.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.